Quick Answer
NovoCure Ltd reported Net Income of -$136.23 million for fiscal year 2025.
NovoCure Ltd Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$136.23M | +19.2% |
| 2024 | -$168.63M | +18.6% |
| 2023 | -$207.04M | -123.7% |
| 2022 | -$92.53M | -58.6% |
| 2021 | -$58.35M | -394.6% |
| 2020 | $19.81M | +374.0% |
| 2019 | -$7.23M | +88.6% |
| 2018 | -$63.56M | -3.1% |
| 2017 | -$61.66M | +53.2% |
| 2016 | -$131.84M | -18.2% |
| 2015 | -$111.58M | -38.3% |
| 2014 | -$80.68M | -4.3% |
| 2013 | -$77.37M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$37.27M | -21.9% | +7.1% |
| June 30, 2025 | -$40.14M | -20.3% | -17.0% |
| March 31, 2025 | -$34.32M | +11.5% | -12.3% |
| September 30, 2024 | -$30.57M | +38.2% | +8.4% |
| June 30, 2024 | -$33.38M | +41.9% | +13.9% |
| March 31, 2024 | -$38.76M | +27.0% | +21.7% |
| September 30, 2023 | -$49.48M | -86.2% | +13.8% |
| June 30, 2023 | -$57.42M | -139.2% | -8.2% |
- NovoCure Ltd showed an increase of +19.2% in Net Income compared to the prior fiscal year.
- Over the 2013–2025 period, NovoCure Ltd’s net income has declined by 76.1% (from -$77.37 million to -$136.23 million).
- The most recent figure is from NovoCure Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: